Bevacizumab - Diabetic macular oedema

You are here : Home > Formulary Search > Bevacizumab - Diabetic macular oedema

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red

Formulations :

Intravitreal injection

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

ICB

Off Label

SPC

Restrictions / Comments :

Documentation

Guidelines (Local)

DIabetic Macular Oedema pathway - September 2022

Evidence Review

Anti-VEGF treatments for non-wet AMD indications - Evidence Review - October 2010.pdf

PAD Profile

ChemicalSubstance :

Bevacizumab

Indication :

Diabetic macular oedema

Group Name :

Keywords :

DMO

Brand Names Include :

Avastin

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Committee Recommendations (0)

No records returned.

Other Indications

Below are listed other indications that Bevacizumab is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Diabetic macular oedema.